Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-17-009016
Filing Date
2017-02-14
Accepted
2017-02-14 17:33:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v459265_sc13ga.htm SC 13G/A 33142
  Complete submission text file 0001144204-17-009016.txt   34924
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-51477 | Film No.: 17610826
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Filed by) CIK: 0001315082 (see all company filings)

EIN.: 830406780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A